Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

2,679 public trials 155 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes

NCT00617565

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
Locations
  • Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
  • Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
  • Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
  • Novo Nordisk Investigational Site Shanghai, Shanghai Municipality, China
View Trial Details
Completed

Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes

NCT01618214

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Hefei, Anhui, China
  • Novo Nordisk Investigational Site Hefei, Anhui, China
  • Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
  • Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
View all 22 locations
View Trial Details
Completed

Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Type 2 Diabetes

NCT01704378

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Kotka, Finland
  • Novo Nordisk Investigational Site Kuopio, Finland
  • Novo Nordisk Investigational Site Lahti, Finland
  • Novo Nordisk Investigational Site Gjøvik, Norway
View all 17 locations
View Trial Details
Completed

Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 Diabetes

NCT01697631

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Bialystok, Poland
  • Novo Nordisk Investigational Site Bytom, Poland
  • Novo Nordisk Investigational Site Kamieniec Ząbkowicki, Poland
  • Novo Nordisk Investigational Site Katowice, Poland
View Trial Details
Completed

Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes

NCT01467401

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Århus C, Denmark
  • Novo Nordisk Investigational Site Esbjerg, Denmark
  • Novo Nordisk Investigational Site Herning, Denmark
  • Novo Nordisk Investigational Site Holbæk, Denmark
View all 57 locations
View Trial Details
Completed

Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes

NCT00469092

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Buenos Aires, Argentina
  • Novo Nordisk Investigational Site Ciudad Autonoma de Bs As, Argentina
  • Novo Nordisk Investigational Site Ciudad Autónoma de BsAs, Argentina
  • Novo Nordisk Investigational Site Mar del Plata, Argentina
View all 69 locations
View Trial Details
Completed

A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.

NCT01128894

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Gilbert, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
View all 173 locations
View Trial Details

Related conditions